Impact of Coronavirus Disease 2019 on Hospital Admissions, Health Status, and Behavioral Changes of Patients with COPD.

COPD COVID-19 endoscopic lung volume reduction lockdown measures

Journal

Chronic obstructive pulmonary diseases (Miami, Fla.)
ISSN: 2372-952X
Titre abrégé: Chronic Obstr Pulm Dis
Pays: United States
ID NLM: 101635411

Informations de publication

Date de publication:
26 Jul 2023
Historique:
medline: 4 5 2023
pubmed: 4 5 2023
entrez: 4 5 2023
Statut: ppublish

Résumé

Patients with chronic obstructive pulmonary disease (COPD) have an increased risk of acquiring severe coronavirus disease 2019 (COVID-19), which is why self-isolation was recommended. However, long periods of social isolation, accompanied by limited access to health care systems, might influence the outcome of patients with severe COPD negatively. Data from COPD and pneumonia patients at Charité-Universitätsmedizin Berlin and the volume of endoscopic lung volume reduction (ELVR) surgeries from the German Lung Emphysema Registry ( Admissions and ventilation therapies administered to COPD patients significantly decreased during the COVID-19 pandemic. Likewise, there was a reduction in ELVR treatments and follow-ups registered in German emphysema centers. Mortality was slightly higher among patients hospitalized with COPD during the pandemic. Increasing proportions of COPD patients with GOLD stage 3 and GOLD stage 4 status reported behavioral changes and subjective feelings of increasing COPD symptoms the longer the lockdown lasted. However, COPD symptom questionnaires revealed stable COPD symptoms over the pandemic time period. This study reveals reduced COPD admissions and elective treatment procedures of COPD patients during the pandemic, but a slight increase in mortality among patients hospitalized with COPD, irrespective of COVID-19. Correspondingly, patients with severe COPD reported subjective deterioration of their health status, probably caused by their very strict compliance with lockdown measures.

Identifiants

pubmed: 37140947
doi: 10.15326/jcopdf.2022.0383
pmc: PMC10484494
doi:

Types de publication

Journal Article

Langues

eng

Pagination

211-223

Subventions

Organisme : CapNetz Stiftung
Pays : Germany
Organisme : Lungenemphysem Register e.V.
Pays : Germany
Organisme : German Research Foundation
ID : SFB1449/114933180
Pays : Germany
Organisme : German Research Foundation
ID : B02
Pays : Germany
Organisme : German Research Foundation
ID : SFB-TR84/114933180
Pays : Germany
Organisme : German Research Foundation
ID : CO6
Pays : Germany
Organisme : German Research Foundation
ID : C09
Pays : Germany
Organisme : German Federal Ministry of Education and Research (BMBF)
ID : E:Med CAPSYS/01ZX1604B
Pays : Germany
Organisme : German Federal Ministry of Education and Research (BMBF)
ID : PROVID/01KI20160A
Pays : Germany
Organisme : German Federal Ministry of Education and Research (BMBF)
ID : e:Med SYMPATH/01ZX1906A
Pays : Germany
Organisme : German Federal Ministry of Education and Research (BMBF)
ID : NUM-NAPKON/01KX2021
Pays : Germany
Organisme : German Federal Ministry of Education and Research (BMBF)
ID : NUM-NAPKON /01KX2121
Pays : Germany
Organisme : German Federal Ministry of Education and Research (BMBF)
ID : Phage4Cure/16GW0141
Pays : Germany
Organisme : German Federal Ministry of Education and Research (BMBF)
ID : MAPVAP/01KI2124
Pays : Germany
Organisme : German Federal Ministry of Education and Research (BMBF)
ID : PulmVasC/01EP2102B
Pays : Germany
Organisme : German Federal Ministry of Education and Research (BMBF)
ID : CAP-TSD/031L0286B
Pays : Germany

Informations de copyright

JCOPDF © 2023.

Références

ERJ Open Res. 2021 Jan 25;7(1):
pubmed: 33532454
Int J Chron Obstruct Pulmon Dis. 2018 Sep 04;13:2731-2738
pubmed: 30233163
N Engl J Med. 2019 Sep 26;381(13):1257-1266
pubmed: 31553837
Thorax. 2022 May;77(5):505-507
pubmed: 34675127
Nature. 2020 Aug;584(7821):430-436
pubmed: 32640463
Respir Med. 2020 Sep;171:106085
pubmed: 32917356
PLoS One. 2022 Mar 24;17(3):e0255185
pubmed: 35324905
Am J Respir Crit Care Med. 2021 Jan 1;203(1):24-36
pubmed: 33146552
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
JAMA. 2020 Aug 4;324(5):510-513
pubmed: 32609307
EClinicalMedicine. 2021 Mar;33:100789
pubmed: 33758801
Respir Med. 2020 Sep;171:106096
pubmed: 32763754
N Engl J Med. 2020 May 21;382(21):2049-2055
pubmed: 32202722
Respiration. 2023;102(3):203-206
pubmed: 36529120
PLoS One. 2020 May 11;15(5):e0233147
pubmed: 32392262
PLoS One. 2021 Aug 3;16(8):e0255659
pubmed: 34343205
N Engl J Med. 2020 Jul 30;383(5):496-498
pubmed: 32348640
BMC Med. 2021 May 17;19(1):124
pubmed: 33993870
Stroke. 2020 Jul;51(7):2228-2231
pubmed: 32432998
Ther Adv Respir Dis. 2022 Jan-Dec;16:17534666221081047
pubmed: 35253548
ERJ Open Res. 2021 Jan 18;7(1):
pubmed: 33527075
COPD. 2021 Apr;18(2):226-230
pubmed: 33764237
Stroke. 2021 Nov;52(11):3651-3660
pubmed: 34344166
ERJ Open Res. 2021 Feb 08;7(1):
pubmed: 33575313
Respir Med Res. 2020 Nov;78:100764
pubmed: 32498023
ESC Heart Fail. 2021 Feb;8(1):333-343
pubmed: 33283476
Chronic Obstr Pulm Dis. 2021 Oct 28;8(4):572-579
pubmed: 34592084
BMJ. 2021 May 24;373:n1135
pubmed: 34035000
Lancet. 2020 Aug 8;396(10248):381-389
pubmed: 32679111
Thorax. 2021 May;76(5):512-513
pubmed: 33273024
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
Lancet. 2020 Jun 27;395(10242):1973-1987
pubmed: 32497510
J Clin Virol. 2021 Apr;137:104795
pubmed: 33761423
Health Policy. 2022 May;126(5):373-381
pubmed: 34924210
Chest. 2021 Jul;160(1):135-138
pubmed: 33444614
BMC Pulm Med. 2020 May 4;20(1):120
pubmed: 32366300
Front Med (Lausanne). 2022 Sep 16;9:995016
pubmed: 36186789

Auteurs

Eva Pappe (E)

Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Ralf Hammerich (R)

Administrative Office for Clinical Quality and Risk Management, Charité- Universitätsmedizin Berlin, Berlin, Germany.

Jacopo Saccomanno (J)

Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Thomas Sgarbossa (T)

Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Anne Pohrt (A)

Institute of Biometry and Clinical Epidemiology, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Bernd Schmidt (B)

Department of Respiratory Medicine, DRK Kliniken Berlin Mitte, Berlin, Germany.

Christian Grah (C)

Department of Internal Medicine and Respiratory Medicine, Clinic Havelhöhe Berlin, Berlin, Germany.

Stephan Eisenmann (S)

Department of Internal Medicine I, Pulmonary Medicine, University Hospital Halle (Saale), Germany.

Angelique Holland (A)

Department of Medicine, Pulmonary and Critical Care Medicine, University Medical Center Giessen and Marburg, Philipps-University Marburg, Marburg, Germany.

Stephan Eggeling (S)

Department of Thoracic Surgery, Vivantes Netzwerk für Gesundheit, Klinikum Neukölln, Berlin, Germany.

Franz Stanzel (F)

Lungenklinik Hemer, Hemer, Germany.

Martin Witzenrath (M)

Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Ralf-Harto Hübner (RH)

Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Classifications MeSH